ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2025
[Application of Explainable Deep Learning in Differentiating Benign from Malignant Pulmonary Space-occupying Lesions and Classifying Pathological Subtypes of Lung Cancer].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe discrimination between benign and malignant pulmonary space-occupying lesions and the classification of pathological subtypes of lung cancer are critical for clinical decision-making. However, conventional methods often suffer from insufficient utilization of multi-source clinical data and poor interpretability of deep learning models. This study investigates the performance of interpretable deep learning algorithms in diagnosing benign versus malignant pulmonary space-occupying lesions and classifying pathological subtypes of lung cancer, using a hybrid architecture based on Tab-Transformer-designed for tabular data and Residual Multi-Layer Perceptron (ResMLP), referred to as TT-ResMLP.
methodsData including radiological characteristics, medical history, and laboratory findings from 345 patients with pathologically confirmed pulmonary space-occupying lesions were collected. The dataset was randomly split into a development set and a test set at an 8:2 ratio. Stable features were selected using the Spearman correlation test and the Least Absolute Shrinkage and Selection Operator (LASSO). The Synthetic Minority Over-sampling Technique (SMOTE) was employed to balance the samples, and 10-fold cross-validation was used to enhance model generalizability. Models were constructed using the Tab-Transformer algorithm, the ResMLP algorithm, and the TT-ResMLP hybrid. Model performance was evaluated using receiver operating characteristic (ROC) curves, the area under the curve (AUC), accuracy, specificity, sensitivity, and micro-averaged ROC (micro-ROC). SHapley Additive exPlanations (SHAP) analysis was performed based on the optimal model.
resultsIn the benign vs malignant diagnosis task, all three models performed well. The Tab-Transformer model demonstrated the best performance on the test set, followed by TT-ResMLP and ResMLP. SHAP analysis of the top-performing Tab-Transformer model revealed that the feature importance ranking was: age, pleural indentation, thrombin time, mean density, and ground-glass opacity. Pleural indentation contributed substantially to malignant diagnosis, and its contribution was further enhanced with increasing age and decreasing thrombin time. In the lung cancer subtype classification task, all three models exhibited excellent performance, with the TT-ResMLP hybrid showing the best overall performance. SHAP analysis further revealed that the Lung Imaging Reporting and Data System (Lung-RADS) category held high importance across all three pathological subtypes. Male gender was positively associated with the prediction of squamous cell carcinoma. Neuron-specific enolase (NSE) played a significant role in predicting small cell carcinoma. For adenocarcinoma, the diagnostic probability was positively correlated with the Lung-RADS category, a relationship more pronounced at lower prothrombin time (PT) values. In contrast, a negative correlation was observed in the squamous cell carcinoma and small cell carcinoma subgroups, although gender and NSE levels could enhance their contributory risk prediction. Analysis of feature decision boundaries indicated that the Lung-RADS grade possessed high discriminative power for identifying adenocarcinoma, whereas NSE demonstrated stronger discriminative ability for identifying small cell carcinoma.
conclusionsThe TT-ResMLP hybrid architecture is effective for diagnosing the benign or malignant nature of pulmonary space-occupying lesions and classifying pathological subtypes of lung cancer. The model possesses good interpretability, aiding in the identification of key predictive features and unravelling their interactive mechanisms, thereby providing an effective tool for a deeper understanding of lung cancer biology and clinical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.